MedPath

Community-Led COVID-19 Testing Intervention to Address Mistrust

Not Applicable
Recruiting
Conditions
COVID-19
Trust
Registration Number
NCT07166770
Lead Sponsor
Old Dominion University
Brief Summary

The goal of this adapted intervention study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Detailed Description

Eligible participants will be randomized to intervention or control group. Intervention group participants will meet virtually with other community member participants in small discussion groups once a week for 75 minutes over the course of 14 weeks. The online discussion groups will be led by peer mentor facilitators and supported by a research team member. Discussion topics will include current events and other health related topics. Control group participants will not meet in weekly discussion groups. At approximately the 0 weeks, 14 weeks, and 18 weeks time points, all participants will answer online surveys about health related topics. At the 14 weeks and 18 weeks time points, all participants will also be asked to self-administer a COVID-19 test that investigators provide.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
56
Inclusion Criteria
  • 18 years or older
  • Resident of one of the 9 housing authority agencies
  • Willing to participate in Zoom meetings and complete online assessments at baseline, 14-week, and 18-week timepoints
  • Ability to read, speak, and understand English
Exclusion Criteria
  • May not have participated in Study 1

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Openness to COVID-19 Testing0 weeks, 14 weeks, 18 weeks

The COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.

COVID-19 Testing Efficacy0 weeks, 14 weeks, 18 weeks

The COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.

COVID-19 Trust0 weeks, 14 weeks, 18 weeks

The COVID-19 Trust Questionnaire is an 18-item self-report measure to assess participants' trust of information provided by various institutions and individuals relating to COVID-19. Each item is rated on a 5-point Likert scale, with the sum of scores ranging from 18 to 90. Higher scores indicate greater trust.

Secondary Outcome Measures
NameTimeMethod
COVID-19 Vaccine Hesitancy0 weeks, 14 weeks, 18 weeks

The Vaccine Hesitancy Questionnaire (VHQ) is an 18-item self-report measure that will assess participants' COVID-19 vaccine hesitancy. The VHQ was adapted from the Parent Attitudes about Childhood Vaccines (PACV) survey and contains 4 subscales: Immunization Behavior, Beliefs about Vaccine Safety and Efficacy, Attitudes about Vaccine Mandates and Exemptions, and Trust. Scores range from 11 to 85, with higher scores indicating greater hesitancy.

Social Connectedness0 weeks, 14 weeks, 18 weeks

The Social Connectedness Scale Revised is a 20-item scale that measures a participant's feeling of connection with other people and their community. Each item is rated on a 6-point scale ranging from 1 "Strongly Disagree" to 6 "Strongly Agree," with the sum of scores ranging between 20 and 120. Higher scores indicate greater connectedness.

Health Literacy0 weeks, 14 weeks, 18 weeks

The Health Literacy Scale (HLS-14) for Adults is a 14-item scale adapted for use in the US that measures an individual's ability to understand, access, and apply health-related information. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 14 and 70. Higher scores indicate greater health literacy.

Trial Locations

Locations (1)

Macon & Joan Brock Virginia Health Institute at Old Dominion University

🇺🇸

Norfolk, Virginia, United States

Macon & Joan Brock Virginia Health Institute at Old Dominion University
🇺🇸Norfolk, Virginia, United States
Kelli J England, PhD
Principal Investigator
Betsy C Conner, CIP
Contact
757-446-5854
ConnerBC@odu.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.